Usfda
-
{
- All
- News
- Videos
-
New Diabetes Generic Drug Gets Approval In US Market: All About Dapagliflozin
Zydus Lifesciences has received USFDA approval for generic dapagliflozin tablets used to treat type 2 diabetes. Here's how the drug works, its benefits, and why it is important for blood sugar control and heart health.
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Glenmark Pharmaceuticals Recalls 1,200 Bottles Of "Subpotent" Hypertension Drug In US
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).
-
US Approves Lab-Grown Chicken To Be Sold In Markets, Twitter Reacts
The United States Department of Agriculture (USDA) has granted approvals to two companies selling chicken grown from animal cells.
-
Elon Musk Expects Brain-Chip Startup Neuralink to Start First Human Trial This Year
Elon Musk expects his brain-chip startup Neuralink to start its first human trial this year, he said on Friday. While Musk didn't specify how many patients his company would implant or for how long, "it's looking like the first case will be later this year," said Musk.
-
Biocon Recalls 3,665 Bottles Of Antifungal Drug In US For "Failed Specifications"
Biotechnology major Biocon is recalling 3,665 bottles of antifungal medication in the US market for "failed degradation specifications", according to the US Food and Drug Administration (USFDA).
-
Starbucks Vanilla Frappuccino Bottles In US Recalled Over Health Safety Concerns
The US Food and Drug Administration said that more than 25,000 cases of the glass bottles have been recalled.
-
"Drug Products Adulterated": US Regulator Warns Sun Pharma's Gujarat Plant
The US health regulator has pulled up drug major Sun Pharma for manufacturing lapses, including failure to follow appropriate written procedures designed to prevent microbiological contamination of drug products, at its Gujarat-based plant.
-
Synchron Switch Now Lets You Control Your iPhone or iPad Using Brain: All Details
Brain chip implant developer Synchron has created a device called 'Synchron Switch' that allows patients to control an iPhone or iPad using their brain. Synchron’s technology could lead to major advances and would change the day-to-day lives of people with severe disabilities.
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer
Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America.
-
New Diabetes Generic Drug Gets Approval In US Market: All About Dapagliflozin
Zydus Lifesciences has received USFDA approval for generic dapagliflozin tablets used to treat type 2 diabetes. Here's how the drug works, its benefits, and why it is important for blood sugar control and heart health.
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Glenmark Pharmaceuticals Recalls 1,200 Bottles Of "Subpotent" Hypertension Drug In US
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).
-
US Approves Lab-Grown Chicken To Be Sold In Markets, Twitter Reacts
The United States Department of Agriculture (USDA) has granted approvals to two companies selling chicken grown from animal cells.
-
Elon Musk Expects Brain-Chip Startup Neuralink to Start First Human Trial This Year
Elon Musk expects his brain-chip startup Neuralink to start its first human trial this year, he said on Friday. While Musk didn't specify how many patients his company would implant or for how long, "it's looking like the first case will be later this year," said Musk.
-
Biocon Recalls 3,665 Bottles Of Antifungal Drug In US For "Failed Specifications"
Biotechnology major Biocon is recalling 3,665 bottles of antifungal medication in the US market for "failed degradation specifications", according to the US Food and Drug Administration (USFDA).
-
Starbucks Vanilla Frappuccino Bottles In US Recalled Over Health Safety Concerns
The US Food and Drug Administration said that more than 25,000 cases of the glass bottles have been recalled.
-
"Drug Products Adulterated": US Regulator Warns Sun Pharma's Gujarat Plant
The US health regulator has pulled up drug major Sun Pharma for manufacturing lapses, including failure to follow appropriate written procedures designed to prevent microbiological contamination of drug products, at its Gujarat-based plant.
-
Synchron Switch Now Lets You Control Your iPhone or iPad Using Brain: All Details
Brain chip implant developer Synchron has created a device called 'Synchron Switch' that allows patients to control an iPhone or iPad using their brain. Synchron’s technology could lead to major advances and would change the day-to-day lives of people with severe disabilities.
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer
Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America.
